Pani Lydie N, Korenda Leslie, Meigs James B, Driver Cynthia, Chamany Shadi, Fox Caroline S, Sullivan Lisa, D'Agostino Ralph B, Nathan David M
Department of Medicine, Diabetes Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Diabetes Care. 2008 Oct;31(10):1991-6. doi: 10.2337/dc08-0577. Epub 2008 Jul 15.
Although glycemic levels are known to rise with normal aging, the nondiabetic A1C range is not age specific. We examined whether A1C was associated with age in nondiabetic subjects and in subjects with normal glucose tolerance (NGT) in two population-based cohorts.
We performed cross-sectional analyses of A1C across age categories in 2,473 nondiabetic participants of the Framingham Offspring Study (FOS) and in 3,270 nondiabetic participants from the National Health and Nutrition Examination Survey (NHANES) 2001-2004. In FOS, we examined A1C by age in a subset with NGT, i.e., after excluding those with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT). Multivariate analyses were performed, adjusting for sex, BMI, fasting glucose, and 2-h postload glucose values.
In the FOS and NHANES cohorts, A1C levels were positively associated with age in nondiabetic subjects. Linear regression revealed 0.014- and 0.010-unit increases in A1C per year in the nondiabetic FOS and NHANES populations, respectively. The 97.5th percentiles for A1C were 6.0% and 5.6% for nondiabetic individuals aged <40 years in FOS and NHANES, respectively, compared with 6.6% and 6.2% for individuals aged >or=70 years (P(trend) < 0.001). The association of A1C with age was similar when restricted to the subset of FOS subjects with NGT and after adjustments for sex, BMI, fasting glucose, and 2-h postload glucose values.
A1C levels are positively associated with age in nondiabetic populations even after exclusion of subjects with IFG and/or IGT. Further studies are needed to determine whether age-specific diagnostic and treatment criteria would be appropriate.
尽管已知血糖水平会随着正常衰老而升高,但非糖尿病患者的糖化血红蛋白(A1C)范围并无年龄特异性。我们在两项基于人群的队列研究中,探讨了非糖尿病受试者以及糖耐量正常(NGT)受试者的A1C水平与年龄之间的关系。
我们对弗雷明汉后代研究(FOS)中的2473名非糖尿病参与者以及2001 - 2004年美国国家健康与营养检查调查(NHANES)中的3270名非糖尿病参与者按年龄类别进行了A1C的横断面分析。在FOS中,我们在NGT亚组中按年龄检查了A1C,即排除了空腹血糖受损(IFG)和/或糖耐量受损(IGT)的受试者后进行分析。进行了多变量分析,并对性别、体重指数(BMI)、空腹血糖和负荷后2小时血糖值进行了校正。
在FOS和NHANES队列中,非糖尿病受试者的A1C水平与年龄呈正相关。线性回归显示,在非糖尿病的FOS和NHANES人群中,A1C每年分别升高0.014和0.010个单位。在FOS和NHANES中,年龄<40岁的非糖尿病个体的A1C第97.5百分位数分别为6.0%和5.6%,而年龄≥70岁的个体则为6.6%和6.2%(趋势P<0.001)。当仅限于FOS中NGT受试者亚组,并对性别、BMI、空腹血糖和负荷后2小时血糖值进行校正后,A1C与年龄的关联相似。
即使排除了IFG和/或IGT受试者,非糖尿病人群的A1C水平仍与年龄呈正相关。需要进一步研究以确定特定年龄的诊断和治疗标准是否合适。